nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—AGTR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0283	0.0283	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0283	0.0283	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0279	0.0279	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0279	0.0279	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0273	0.0273	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0253	0.0253	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0253	0.0253	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0244	0.0244	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—HCRT—narcolepsy	0.0232	0.0232	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0219	0.0219	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0219	0.0219	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0211	0.0211	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0208	0.0208	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—PENK—narcolepsy	0.0204	0.0204	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DQA1—narcolepsy	0.0196	0.0196	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0187	0.0187	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0187	0.0187	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DQB1—narcolepsy	0.0183	0.0183	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0181	0.0181	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—TRH—narcolepsy	0.0176	0.0176	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—TRH—narcolepsy	0.0174	0.0174	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0157	0.0157	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0154	0.0154	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HCRTR1—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HCRTR2—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DRB1—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—P2RY11—narcolepsy	0.0138	0.0138	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—NPS—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—TAC1—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—NPS—narcolepsy	0.0126	0.0126	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0126	0.0126	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HCRT—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—PENK—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.0095	0.0095	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TRH—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00847	0.00847	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00847	0.00847	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00806	0.00806	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00806	0.00806	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00782	0.00782	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00778	0.00778	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HRH3—narcolepsy	0.00778	0.00778	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00773	0.00773	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00769	0.00769	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00732	0.00732	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00732	0.00732	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—P2RY11—narcolepsy	0.00707	0.00707	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00688	0.00688	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HCRT—narcolepsy	0.00662	0.00662	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—narcolepsy	0.00659	0.00659	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—NPS—narcolepsy	0.00645	0.00645	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TAC1—narcolepsy	0.00645	0.00645	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HCRT—narcolepsy	0.00601	0.00601	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00595	0.00595	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PENK—narcolepsy	0.0059	0.0059	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PENK—narcolepsy	0.00536	0.00536	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00526	0.00526	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CHKB—narcolepsy	0.00512	0.00512	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00509	0.00509	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TRH—narcolepsy	0.00502	0.00502	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TRH—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HRH3—narcolepsy	0.0044	0.0044	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HCRTR2—narcolepsy	0.00432	0.00432	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HCRTR1—narcolepsy	0.00432	0.00432	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—P2RY11—narcolepsy	0.00418	0.00418	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HRH3—narcolepsy	0.00399	0.00399	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR2A—narcolepsy	0.00388	0.00388	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TAC1—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPS—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HCRT—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CPT1B—narcolepsy	0.00348	0.00348	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CHKB—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPS—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TAC1—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PENK—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TRH—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRH3—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CPT1B—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2A—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—narcolepsy	0.00199	0.00199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TAC1—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—narcolepsy	0.00118	0.00118	CbGpPWpGaD
